Ligand Pharmaceuticals
LGND
#3601
Rank
C$5.02 B
Marketcap
C$255.40
Share price
-1.93%
Change (1 day)
44.61%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2025 (TTM): C$88.66 Million

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are C$0.25 Billion. In 2024 the company made an earning of C$7.66 Million a decrease over its 2023 earnings that were of C$88.85 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$88.66 M1056.23%
2024 C$7.66 M-91.37%
2023 C$88.85 M-7.59%
2022 C$96.15 M4%
2021 C$92.45 M296.42%
2020 C$23.32 M-97.97%
2019 C$1.14 B275.62%
2018 C$0.30 B237.48%
2017 C$90.71 M49.05%
2016 C$60.86 M55.41%
2015 C$39.16 M36.87%
2014 C$28.61 M29.59%
2013 C$22.07 M1309.35%
2012 C$1.56 M-43.97%
2011 C$2.79 M-113.19%
2010 -C$21.2 Million59.86%
2009 -C$13.27 Million-61.33%
2008 -C$34.3 Million-58.75%
2007 -C$83.14 Million20.52%
2006 -C$68.98 Million81.27%
2005 -C$38.06 Million
2003 -C$26.5 Million-20.6%
2002 -C$33.37 Million4.38%
2001 -C$31.97 Million-48.83%
2000 -C$62.47 Million-19.74%
1999 -C$77.83 Million-19.06%
1998 -C$96.16 Million126.71%
1997 -C$42.42 Million-5.83%
1996 -C$45.04 Million136.23%
1995 -C$19.07 Million-33.97%
1994 -C$28.88 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
C$11.38 B 12,242.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-C$85.49 Million-192.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$12.87 B 13,857.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
C$31.89 B 34,469.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$16.37 B 17,644.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$31.08 B 33,591.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$11.09 B 11,926.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-C$0.38 Billion-504.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$44.75 B 48,402.09%๐Ÿ‡บ๐Ÿ‡ธ USA